Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Guillaume Précigout"'
Autor:
Christina Gedicke‐Hornung, Verena Behrens‐Gawlik, Silke Reischmann, Birgit Geertz, Doreen Stimpel, Florian Weinberger, Saskia Schlossarek, Guillaume Précigout, Ingke Braren, Thomas Eschenhagen, Giulia Mearini, Stéphanie Lorain, Thomas Voit, Patrick A. Dreyfus, Luis Garcia, Lucie Carrier
Publikováno v:
EMBO Molecular Medicine, Vol 5, Iss 7, Pp 1128-1145 (2013)
Abstract Exon skipping mediated by antisense oligoribonucleotides (AON) is a promising therapeutic approach for genetic disorders, but has not yet been evaluated for cardiac diseases. We investigated the feasibility and efficacy of viral‐mediated A
Externí odkaz:
https://doaj.org/article/2151f46ca23e4c23b5b19581f81c7297
Autor:
Giulia Mearini, Doreen Stimpel, Elisabeth Krämer, Birgit Geertz, Ingke Braren, Christina Gedicke-Hornung, Guillaume Précigout, Oliver J Müller, Hugo A Katus, Thomas Eschenhagen, Thomas Voit, Luis Garcia, Stéphanie Lorain, Lucie Carrier
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
RNA trans-splicing has been explored as a therapeutic option for a variety of genetic diseases, but not for cardiac genetic disease. Hypertrophic cardiomyopathy (HCM) is an autosomal-dominant disease, characterized by left ventricular hypertrophy (LV
Externí odkaz:
https://doaj.org/article/71f14212fc7c4a9d880522573ae986ba
Autor:
Stéphane Vassilopoulos, Christel Gentil, Jeanne Lainé, Pierre-Olivier Buclez, Agathe Franck, Arnaud Ferry, Guillaume Précigout, Robyn Roth, John E. Heuser, Frances M. Brodsky, Luis Garcia, Gisèle Bonne, Thomas Voit, France Piétri-Rouxel, Marc Bitoun
Publikováno v:
Journal of Cell Biology
Journal of Cell Biology, Rockefeller University Press, 2014, 205 (3), pp.377-393. ⟨10.1083/jcb.201309096⟩
The Journal of Cell Biology
Journal of Cell Biology, Rockefeller University Press, 2014, 205 (3), pp.377-393. ⟨10.1083/jcb.201309096⟩
The Journal of Cell Biology
Clathrin heavy chain contributes to the formation and maintenance of the contractile apparatus in skeletal muscle through interactions with costameric proteins.
The ubiquitous clathrin heavy chain (CHC), the main component of clathrin-coated ves
The ubiquitous clathrin heavy chain (CHC), the main component of clathrin-coated ves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23cc1eaacdaabc988c77539dbee3c46c
https://hal.archives-ouvertes.fr/hal-02453865/file/Vassilopoulos-2014-HAL.pdf
https://hal.archives-ouvertes.fr/hal-02453865/file/Vassilopoulos-2014-HAL.pdf
Autor:
Giulia Mearini, Ingke Braren, Christina Gedicke-Hornung, Saskia Schlossarek, Stéphanie Lorain, Guillaume Précigout, Thomas Voit, Verena Behrens-Gawlik, Birgit Geertz, Patrick A. Dreyfus, Lucie Carrier, Florian Weinberger, Silke Reischmann, Doreen Stimpel, Luis Garcia, Thomas Eschenhagen
Publikováno v:
EMBO Molecular Medicine
EMBO Molecular Medicine, 2013, 5 (7), pp.1128-1145. ⟨10.1002/emmm.201202168⟩
EMBO Molecular Medicine, Wiley Open Access, 2013, 5 (7), pp.1128-1145. ⟨10.1002/emmm.201202168⟩
EMBO Molecular Medicine; Vol 5
EMBO Molecular Medicine, 2013, 5 (7), pp.1128-1145. ⟨10.1002/emmm.201202168⟩
EMBO Molecular Medicine, Wiley Open Access, 2013, 5 (7), pp.1128-1145. ⟨10.1002/emmm.201202168⟩
EMBO Molecular Medicine; Vol 5
International audience; Exon skipping mediated by antisense oligoribonucleotides (AON) is a promising therapeutic approach for genetic disorders, but has not yet been evaluated for cardiac diseases. We investigated the feasibility and efficacy of vir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c03d31be7d4883e87e9e3d0291e81d3e
https://hal.sorbonne-universite.fr/hal-01549077
https://hal.sorbonne-universite.fr/hal-01549077
Autor:
Luis Garcia, Hugo A. Katus, Ingke Braren, Christina Gedicke-Hornung, Elisabeth Krämer, Doreen Stimpel, Giulia Mearini, Guillaume Précigout, Stéphanie Lorain, Oliver J. Müller, Thomas Voit, Birgit Geertz, Thomas Eschenhagen, Lucie Carrier
Publikováno v:
Molecular Therapy-Nucleic Acids
Molecular Therapy-Nucleic Acids, Elsevier, 2013, 2, pp.e102. ⟨10.1038/mtna.2013.31⟩
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
Molecular Therapy—Nucleic Acids
Molecular Therapy-Nucleic Acids, 2013, 2, pp.e102. ⟨10.1038/mtna.2013.31⟩
Molecular Therapy. Nucleic Acids
Molecular Therapy-Nucleic Acids, Elsevier, 2013, 2, pp.e102. ⟨10.1038/mtna.2013.31⟩
Molecular Therapy: Nucleic Acids, Vol 2, Iss C (2013)
Molecular Therapy—Nucleic Acids
Molecular Therapy-Nucleic Acids, 2013, 2, pp.e102. ⟨10.1038/mtna.2013.31⟩
Molecular Therapy. Nucleic Acids
RNA trans-splicing has been explored as a therapeutic option for a variety of genetic diseases, but not for cardiac genetic disease. Hypertrophic cardiomyopathy (HCM) is an autosomal-dominant disease, characterized by left ventricular hypertrophy (LV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bce2215baf13c470a505a969f9150e9c
Autor:
Arnaud F. Klein, Masanori P. Takahashi, Jocelyn Laporte, Guillaume Bassez, Alban Vignaud, Adolfo López de Munain, Ichizo Nishino, Pascale Zimmermann, Anne Toussaint, Charlotte Boulade-Ladame, Didier Auboeuf, Rie Tsuburaya, Pierre de la Grange, Doulaye Dembélé, Valérie Tosch, Bjarne Udd, Virginie Francois, Nadia Messaddeq, Marie-Christine Hummel, Luis Garcia, Ylva Ivarsson, Stéphane Vassilopoulos, Nicolas Sergeant, Annie Laquerrière, Nicolas Charlet-Berguerand, Guillaume Précigout, Yosuke Kokunai, Benedikt Schoser, Christelle Thibault, C. Hammer, François Deryckere, Denis Furling, Charlotte Fugier, Arnaud Ferry
Publikováno v:
Nature Medicine
Nature Medicine, 2011, 17 (6), pp.720-5. ⟨10.1038/nm.2374⟩
Nature Medicine, Nature Publishing Group, 2011, 17 (6), pp.720-725. ⟨10.1038/nm.2374⟩
Nature Medicine, Nature Publishing Group, 2011, 17 (6), pp.720-5. ⟨10.1038/nm.2374⟩
Nature Medicine, 2011, 17 (6), pp.720-5. ⟨10.1038/nm.2374⟩
Nature Medicine, Nature Publishing Group, 2011, 17 (6), pp.720-725. ⟨10.1038/nm.2374⟩
Nature Medicine, Nature Publishing Group, 2011, 17 (6), pp.720-5. ⟨10.1038/nm.2374⟩
International audience; Myotonic dystrophy is the most common muscular dystrophy in adults and the first recognized example of an RNA-mediated disease. Congenital myotonic dystrophy (CDM1) and myotonic dystrophy of type 1 (DM1) or of type 2 (DM2) are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05ddb1744effec00549fd70e0be4e6fb
https://pubmed.ncbi.nlm.nih.gov/21623381
https://pubmed.ncbi.nlm.nih.gov/21623381
Autor:
Nicolas Cagnard, Luis Garcia, Athanassia Sotiropoulos, Guillaume Précigout, Maryline Favier, Dany Graindorge, David Tuil, Laura Collard, Sabrina Batonnet-Pichon, Charlotte Lahoute, Sophie Hébrard, Dominique Daegelen, Aline Guerci
Publikováno v:
Cell Metabolism. (1):25-37
SummaryAdult skeletal muscles adapt their fiber size to workload. We show that serum response factor (Srf) is required for satellite cell-mediated hypertrophic muscle growth. Deletion of Srf from myofibers and not satellite cells blunts overload-indu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ff4f82518c5a888fa44074a582bc818
Autor:
Gabriella Dias Florencio, Guillaume Precigout, Cyriaque Beley, Pierre-Olivier Buclez, Luis Garcia, Rachid Benchaouir
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 2, Iss , Pp - (2015)
Recombinant adeno-associated viruses (rAAV) are promising candidates for gene therapy approaches. The last two decades were particularly fruitful in terms of processes applied in the production and purification of this type of gene transfer vectors.
Externí odkaz:
https://doaj.org/article/4b292448e03f4d25996b5f5abceaeb4b